King® Guide to Parenteral Admixtures®

Online Edition

Welcome to the King Guide to Parenteral Admixtures Internet Edition.

Enter Login Information



License Agreement


Fall 2022

In this update we added a new monograph for MARGETUXIMAB-CMKB and METHYLPHENIDATE HYDROCHLORIDE.

We also added new stability information to the monographs for CEFTOLOZANE AND TAZOBACTAM, CEFUROXIME SODIUM, FILGRASTIM, INSULIN ASPART, INSULIN GLULISINE, INSULIN LISPRO, LEVETIRACETAM, PIPERACILLIN AND TAZOBACTAM, and VANCOMYCIN HYDROCHLORIDE.

New compatibility information was added to the existing drug monograph for IMIPENEM, CILASTATIN, and RELEBACTAM with 52 other drugs.

  © 2022 - King Guide Publications, Inc. All rights reserved.